Welcome to our dedicated page for Afya SEC filings (Ticker: AFYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Afya's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Afya's regulatory disclosures and financial reporting.
Afya Ltd Vice President Junior Lelio de Souza sold Class A shares in an open-market trade. He sold 26,753 Class A common shares at $14.95 per share and now directly holds 16,279 shares. This was a straightforward sale of existing stock, with no derivatives reported.
Afya Ltd executive Anibal Jose Grifo de Sousa, VP Legal, Compliance and Government Relations, conducted an open-market sale of 5,000 Class A Common Shares on April 7, 2026 at $15.20 per share. After this transaction, he continues to hold 45,000 Class A Common Shares directly, indicating he retains a substantial personal stake in the company despite trimming his position.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported open-market sales of Class A common shares. On April 2, he sold 20,900 shares at $14.94 per share, and on April 6, he sold 770 shares at $14.91 per share.
After these sales, he holds 108,448 Class A shares directly and an additional 200,000 Class A shares indirectly through GIBBOAT OVERSEAS LTD, which is solely owned and controlled by him. The 21,670 shares sold represent a small portion of his overall position.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported open-market sales of 21,820 Class A Common Shares of Afya Ltd over two days. He sold 19,500 shares on April 1, 2026 at $14.98 per share and 2,320 shares on March 31, 2026 at $14.92 per share.
Following these transactions, he holds 130,118 Class A Common Shares directly. He also has an indirect holding of 200,000 Class A Common Shares through GIBBOAT OVERSEAS LTD, which the footnote states is solely owned and controlled by him.
Afya Limited files its annual report prepared under IFRS, presenting consolidated results in Brazilian reais with convenience translations at R$5.5024 per US$1.00. The company operates a large medical and health‑education ecosystem in Brazil through undergraduate, continuing education and digital medical solutions.
The report emphasizes extensive risk factors: intense competition in medical and graduate education, rapid technological change including artificial intelligence, and heavy exposure to Brazilian regulation of medical school openings and enrollment caps. Afya is also highly dependent on government programs such as FIES and PROUNI, Brazilian tax reform (IBS, CBS, Pillar Two and a new 10% dividend withholding), and close MEC supervision via ENADE and ENAMED scores, which can trigger sanctions affecting seats, programs and access to public funding.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported open-market sales of Class A Common Shares. He sold 1,510 shares at $14.91 per share on March 30, 2026 and 300 shares at $15.00 per share on March 27, 2026, totaling 1,810 shares sold.
After these transactions, he directly holds 151,938 Class A Common Shares. In addition, 200,000 Class A Common Shares are held indirectly through GIBBOAT OVERSEAS LTD, which is solely owned and controlled by him, indicating a substantially larger remaining overall position.
XP Investments US, LLC submitted a Form 144 disclosing an intended sale of Class A common shares of Afya Limited.
The filing lists securities acquired under compensation plans: 36,000 shares acquired pursuant to an S-8 stock option plan on 04/25/2025 and 7,032 shares from a Restricted Share Units program on 05/01/2025.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported open-market sales of Class A common shares. On March 25, 2026, he sold 3,900 shares at $15.18 per share, and on March 26, 2026 he sold 800 shares at $15.21 per share, totaling 4,700 shares sold. After these transactions, he directly holds 153,748 Class A shares and indirectly holds 200,000 Class A shares through GIBBOAT OVERSEAS LTD, which is solely owned and controlled by him.
AFYA submitted a Form 144 notice proposing the sale of Class A common shares. The filing lists planned sale activity tied to equity compensation events, with representative entries including 23,500 and 14,051 shares acquired under company plans on 06/10/2025 and 05/01/2025.
The excerpt ties the shares to stock option and restricted share unit programs and reports transaction dates; timing and aggregate offer amount are not stated in the provided excerpt.
Afya Ltd director Esteves Nicolau Carvalho has amended his insider holdings disclosure. The Form 3/A restates his positions without reporting any new purchases or sales. He now reports indirect ownership, through NRE Capital Ventures Ltd., of 4,500,000 Class B common shares, each linked to 4,500,000 underlying Class A common shares, plus 5,321,379 Class A common shares, and direct ownership of 13,916 Class A common shares.
The amendment clarifies that NRE Capital Ventures Ltd. is owned by Carvalho and his wife, Rosangela Esteves, correcting an earlier filing that had described him as the sole owner and controller.